Renaud Sabatier
Centre National de la Recherche Scientifique(FR)Centre National de la Recherche Scientifique(FR)AOL (United States)(US)Inserm(FR)Inserm(FR)Aix-Marseille Université(FR)Centre Hospitalier Universitaire de Caen(FR)Arcagy Gineco(FR)Centre de Recherche en Cancérologie de Marseille(FR)Institut Paoli-Calmettes(FR)Université de Caen Normandie(FR)
Publications by Year
Research Areas
Endometrial and Cervical Cancer Treatments, Ovarian cancer diagnosis and treatment, Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Prognostic and predictive value of PDL1 expression in breast cancer(2014)496 cited
- → Clinical Activity and Safety of the Anti–Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair–Deficient Endometrial Cancer(2020)349 cited
- → Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer(2023)336 cited
- → Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, single-arm study(2022)305 cited
- → A gene expression signature identifies two prognostic subgroups of basal breast cancer(2010)285 cited
- → PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences are Emerging—A Literature Review(2019)